Td Private Client Wealth LLC Sarepta Therapeutics, Inc. Transaction History

Td Private Client Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 16, 2024	SELL	$63.15 - $90.42 $442 - $632	-7 Closed	0 $0
Q4 2021 Aug 16, 2024	SELL	$77.28 - $99.42 $2,395 - $3,082	-31 Reduced 81.58%	7 $630,000
Q3 2021 Aug 16, 2024	BUY	$65.97 - $92.48 $2,506 - $3,514	38 New	38 $3.51 Million
Q1 2021 Aug 16, 2024	SELL	$72.25 - $168.95 $1,517 - $3,547	-21 Reduced 50.0%	21 $1.57 Million
Q2 2020 Aug 16, 2024	SELL	$93.0 - $171.7 $744 - $1,373	-8 Reduced 16.0%	42 $6.73 Million
Q1 2020 Aug 16, 2024	BUY	$82.38 - $131.64 $164 - $263	2 Added 4.17%	50 $4.89 Million
Q4 2019 Aug 16, 2024	BUY	$76.53 - $135.58 $3,673 - $6,507	48 New	48 $6.19 Million

548

85.8M

3.64M

1.68M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.6B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.